Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	monooxygenase activity	CYP24A1 CYP20A1 FOXRED2 MSMO1 CMAHP NOS1 NOS2 CYP4V2 CYP4Z1 CYP4Z2P	4.94e-07	115	216	10	GO:0004497
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	CYP24A1 CYP20A1 MSMO1 FTO CMAHP NOS1 NOS2 CYP4V2 CYP4Z1 CYP4Z2P KDM4A	8.98e-06	194	216	11	GO:0016705
GeneOntologyMolecularFunction	modification-dependent protein binding	TNIP1 CHD1 PSME4 GLYR1 MINDY2 ANKRD13A CHD5 DZIP3 KDM4A EP300	8.58e-05	206	216	10	GO:0140030
GeneOntologyMolecularFunction	actin filament binding	MYO9A MYO10 SPTBN2 FMNL2 ERMN FGD4 SYNE1 MYO18A FMNL3 MYO1F	1.90e-04	227	216	10	GO:0051015
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	KIF18A RAB8B RAB22A MCM2 CHD1 DDX5 RAB10 MDN1 RAB43 DDX60L RAB27B RAB31 RASA1 DYNC2H1 MYO18A YTHDC2 ATP10A CHD5 AQR SMC1B	3.01e-04	775	216	20	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	KIF18A RAB8B RAB22A MCM2 CHD1 DDX5 RAB10 MDN1 RAB43 ENPP5 DDX60L RAB27B RAB31 RASA1 DYNC2H1 MYO18A YTHDC2 ATP10A CHD5 AQR SMC1B	3.19e-04	839	216	21	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	KIF18A RAB8B RAB22A MCM2 CHD1 DDX5 RAB10 MDN1 RAB43 ENPP5 DDX60L RAB27B RAB31 RASA1 DYNC2H1 MYO18A YTHDC2 ATP10A CHD5 AQR SMC1B	3.25e-04	840	216	21	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	KIF18A RAB8B RAB22A MCM2 CHD1 DDX5 RAB10 MDN1 RAB43 ENPP5 DDX60L RAB27B RAB31 RASA1 DYNC2H1 MYO18A YTHDC2 ATP10A CHD5 AQR SMC1B	3.25e-04	840	216	21	GO:0016818
GeneOntologyMolecularFunction	nitric-oxide synthase activity	NOS1 NOS2	3.47e-04	3	216	2	GO:0004517
GeneOntologyMolecularFunction	ATP-dependent activity	KIF18A MYO9A MYO10 MCM2 CHD1 DDX5 MDN1 DDX60L DYNC2H1 MYO18A UBA3 YTHDC2 ATP10A CHD5 MYO1F AQR SMC1B	3.90e-04	614	216	17	GO:0140657
GeneOntologyMolecularFunction	iron ion binding	CYP24A1 CYP20A1 MSMO1 FTO CYP4V2 CYP4Z1 CYP4Z2P ALOXE3	4.60e-04	166	216	8	GO:0005506
GeneOntologyMolecularFunction	tetrahydrobiopterin binding	NOS1 NOS2	6.89e-04	4	216	2	GO:0034617
GeneOntologyMolecularFunction	actin binding	KIF18A MYO9A MYO10 SPTBN2 FMNL2 ERMN DST FGD4 NOS2 SYNE1 MYO18A FMNL3 MYO1F PRKCE	7.57e-04	479	216	14	GO:0003779
Domain	-	PKDREJ LIPG DENND5B ALOXE3	8.15e-05	21	211	4	2.60.60.20
Domain	PLAT	PKDREJ LIPG DENND5B ALOXE3	8.15e-05	21	211	4	PF01477
Domain	PLAT/LH2_dom	PKDREJ LIPG DENND5B ALOXE3	8.15e-05	21	211	4	IPR001024
Domain	PLAT	PKDREJ LIPG DENND5B ALOXE3	8.15e-05	21	211	4	PS50095
Domain	Spectrin	TRIO SPTBN2 DST SYNE1	1.18e-04	23	211	4	PF00435
Domain	RRM_3	SSB LARP7	1.27e-04	2	211	2	PF08777
Domain	CATSPERD	CATSPERE CATSPERD	1.27e-04	2	211	2	PF15020
Domain	CATSPERD	CATSPERE CATSPERD	1.27e-04	2	211	2	IPR028751
Domain	La_RRM	SSB LARP7	1.27e-04	2	211	2	IPR014886
Domain	RAB	RAB8B RAB22A RAB10 RAB43 RAB27B RAB31	1.76e-04	73	211	6	PS51419
Domain	Spectrin_repeat	TRIO SPTBN2 DST SYNE1	3.01e-04	29	211	4	IPR002017
Domain	NO_synthase	NOS1 NOS2	3.78e-04	3	211	2	PF02898
Domain	Lupus_La	SSB LARP7	3.78e-04	3	211	2	IPR002344
Domain	NOS_euk	NOS1 NOS2	3.78e-04	3	211	2	IPR012144
Domain	-	NOS1 NOS2	3.78e-04	3	211	2	3.90.340.10
Domain	NOS_N	NOS1 NOS2	3.78e-04	3	211	2	IPR004030
Domain	NOS	NOS1 NOS2	3.78e-04	3	211	2	PS60001
Domain	SPEC	TRIO SPTBN2 DST SYNE1	4.44e-04	32	211	4	SM00150
Domain	Spectrin/alpha-actinin	TRIO SPTBN2 DST SYNE1	4.44e-04	32	211	4	IPR018159
Domain	P-loop_NTPase	KIF18A MYO9A MYO10 RAB8B RAB22A MCM2 CHD1 DDX5 RAB10 MDN1 RAB43 DDX60L RAB27B RAB31 DYNC2H1 MYO18A YTHDC2 CHD5 MYO1F AQR SMC1B	6.39e-04	848	211	21	IPR027417
Pathway	REACTOME_RAB_GERANYLGERANYLATION	RAB8B RAB22A RAB10 RAB43 RAB27B RABGGTA RAB31	6.35e-06	65	153	7	M27771
Pathway	REACTOME_RAB_GERANYLGERANYLATION	RAB8B RAB22A RAB10 RAB43 RAB27B RABGGTA RAB31	6.35e-06	65	153	7	MM15511
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	GBF1 TRIO PPRC1 MYO10 LONRF1 PIGG PRAG1 TYK2 DST MDN1 PSME4 RAB43 CPVL ARHGAP21 RARG POLE KHNYN UBR4 MUS81 WDR59 CELSR2 CHD5 TANC1 LRBA IL17RD LSM10 EP300 CEP170B	3.70e-10	1105	217	28	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 UAP1 GBF1 TRIO MYO9A PITPNC1 PRAG1 DST MDN1 SYDE2 ARHGAP21 WDR62 EDC3 ARHGEF28 CALU ALPK1 CDC14A WDR59 PRKCE TANC1 CEP170B AQR	2.79e-08	861	217	22	36931259
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TRIO MYO9A DST ARHGAP21 WDR62 EDC3 YTHDC2 ZDBF2 TBC1D8 TANC1 CEP170B	9.37e-08	209	217	11	36779422
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	RAB22A ZMYM2 CHD1 ERMP1 PIGG CMAS RAB10 DST MDN1 INTS2 FGD4 SUPT6H DNASE1L1 ASF1A CKMT1A UXS1 EDC3 SYNE1 YTHDC2 LARP7 SLC30A6 ORMDL1 RBMX2 CSNK2A2 TANC1 THAP12 CEP170B AQR	2.40e-07	1497	217	28	31527615
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	DCAF1 MIS18BP1 MYO10 VPS13C ETV3 FAT2 SYNE1 HMCN1 EP300	5.26e-07	152	217	9	34299191
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	DCAF1 ETV3 ZMYM2 SSB MDN1 INTS2 XPO5 RMND5B UBR4 ZDBF2 CSNK2A2	1.83e-06	282	217	11	23667531
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DCAF1 DOCK4 FNBP1 PPRC1 MYO10 XPO5 SV2A ARHGAP21 SYNE1 KHNYN DZIP3 CEP170B AQR	1.95e-06	407	217	13	12693553
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	FNBP1 PDE4D TRIO MYO9A VPS13C BRWD3 TYK2 RAB10 INTS2 TECPR2 SUPT6H GLYR1 ENPP5 CYP4V2 ZNF793 UXS1 RASA1 ATP10A DPP9 SLC16A14 PRKCE TANC1 LRBA IMMP2L EP300 CEP170B	2.38e-06	1489	217	26	28611215
Pubmed	UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover.	DCAF1 KBTBD7 BRWD3 UBE3A UBR4 UBXN7	2.53e-06	62	217	6	18775313
Pubmed	Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors.	RAB8B RAB22A RAB10 RAB27B DENND5B	3.35e-06	37	217	5	20937701
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GBF1 TRIO VPS13C GART MCM2 CHD1 SSB DDX5 MDN1 XPO5 SUPT6H GLYR1 ASF1A GOT2 CKMT1A DYNC2H1 CALU SYNE1 POLE UBR4 YTHDC2 APOB LARP7 CSNK2A2 AQR	3.48e-06	1425	217	25	30948266
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DCAF1 DOCK4 MYO10 DST SV2A SYNE1 UBXN7	3.50e-06	101	217	7	9872452
Pubmed	Rab GTPases regulating phagosome maturation are differentially recruited to mycobacterial phagosomes.	RAB8B RAB22A RAB43 RAB31	4.21e-06	18	217	4	21255211
Pubmed	Screening for target Rabs of TBC (Tre-2/Bub2/Cdc16) domain-containing proteins based on their Rab-binding activity.	RAB8B RAB22A RAB10 RAB43 RAB27B RAB31	6.10e-06	72	217	6	16923123
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GABRD TRIO PPRC1 LONRF1 SPTBN2 ZMYM2 USP9Y CMAS FMNL2 ZKSCAN5 BRWD3 DST UBE3A ENPP5 ARHGAP21 ZNF793 SYNE1 UBR4 UBA3 WDR59 KDM4A LRBA EP300	6.36e-06	1285	217	23	35914814
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TRIO SERPINF1 SSB DDX5 SUPT6H ASF1A NPTX1 EDC3 UBR4 YTHDC2 LARP7 DZIP3 INPP5J	1.03e-05	475	217	13	31040226
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PDE4D TRIO MYO9A SPTBN2 SSB CMAS FMNL2 DDX5 ERMN RAB10 DST FGD4 SV2A NOS1 ARHGAP21 GOT2 CKMT1A SYNE1 MYO18A YTHDC2 CSNK2A2 PRKCE TANC1 CEP170B	1.17e-05	1431	217	24	37142655
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FNBP1 ZMYM2 RAB10 MDN1 UBE3A CPVL DYNC2H1 CALU POLE UBR4 ZDBF2 CSNK2A2 IRAK3 IL17RD EP300	1.31e-05	638	217	15	31182584
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GBF1 SPTBN2 TNIP1 FMNL2 ZKSCAN5 FAT2 PDZRN4 ARHGEF28 DYNC2H1 DGKD ALPK1 ATP10A WDR59	1.53e-05	493	217	13	15368895
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SPTBN2 GART CHD1 SSB DST MDN1 XPO5 SUPT6H GLYR1 POLE UBR4 YTHDC2 LARP7 CSNK2A2 AQR	1.72e-05	653	217	15	22586326
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	EFCAB5 DDX5 FAT2 DST MDN1 SYNE1 OVCH1 SLC15A1 LRBA	1.79e-05	234	217	9	36243803
Pubmed	Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data.	LIPG APOB CELSR2	1.96e-05	9	217	3	20370913
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	DOCK4 TRIO MYO9A RAB8B GART ZMYM2 MCM2 CHD1 SSB FGD4 SYDE2 CPVL ARHGAP21 RAB31 ARHGEF28 PLEKHG4 CALU WDR59	2.02e-05	916	217	18	32203420
Pubmed	Human CIA2A-FAM96A and CIA2B-FAM96B integrate iron homeostasis and maturation of different subsets of cytosolic-nuclear iron-sulfur proteins.	FMNL2 EDC3 POLE FMNL3 DPP9 ELP2	2.08e-05	89	217	6	23891004
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DOCK4 MIS18BP1 MYO9A ZMYM2 TNIP1 DDX5 SUPT6H OTUD5 DYNC2H1 PPM1D ZDBF2 TBC1D8 TANC1 CEP170B	2.23e-05	588	217	14	38580884
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCAF1 PNMA1 CMAS FMNL2 ZKSCAN5 BRWD3 TYK2 SV2A WDR62 SEMG1 CALU C16orf96 YTHDC2 LARP7 CBY2 CSNK2A2 CHD5 TANC1 EP300 CEP170B	2.58e-05	1116	217	20	31753913
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	VPS13C MCM2 ERMP1 DST PSME4 INTS2 TECPR2 SUPT6H FTO FMNL3 CHD5 UBXN7 KDM4A	3.18e-05	529	217	13	14621295
Pubmed	Systematic protein-protein interaction mapping for clinically relevant human GPCRs.	GABRD FNBP1 PNMA1 SPTBN2 PIGG BDKRB1 TMEM62 DST MSMO1 TECPR2 SV2A NPTX1 SYNE1 UBR4 IL17RD	3.64e-05	697	217	15	28298427
Pubmed	Neuronal Differentiation in Schwann Cell Lineage Underlies Postnatal Neurogenesis in the Enteric Nervous System.	SV2A NOS1 NOS2	3.81e-05	11	217	3	26156989
Pubmed	Sublethal simulated ischemia promotes delayed resistance against ischemia via ATP-sensitive (K+) channels in murine myocytes: role of PKC and iNOS.	NOS2 PRKCE	3.88e-05	2	217	2	15025939
Pubmed	Serum levels of pigment epithelium-derived factor, a novel marker of insulin resistance, are independently associated with fasting apolipoprotein B48 levels in humans.	SERPINF1 APOB	3.88e-05	2	217	2	22827961
Pubmed	Eugenolol and glyceryl-isoeugenol suppress LPS-induced iNOS expression by down-regulating NF-kappaB AND AP-1 through inhibition of MAPKS and AKT/IkappaBalpha signaling pathways in macrophages.	NFKBIA NOS2	3.88e-05	2	217	2	21658309
Pubmed	N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization.	FTO YTHDC2	3.88e-05	2	217	2	33713148
Pubmed	Association study of the 15q11-q13 maternal expression domain in Japanese autistic patients.	UBE3A ATP10A	3.88e-05	2	217	2	18186074
Pubmed	Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.	NOS1 NOS2	3.88e-05	2	217	2	7682706
Pubmed	The role of nitric oxide synthases in the sleep responses to tumor necrosis factor-alpha.	NOS1 NOS2	3.88e-05	2	217	2	15157956
Pubmed	The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.	CYP4Z1 CYP4Z2P	3.88e-05	2	217	2	28236635
Pubmed	Effects of ethanol on neutrophil recruitment and lung host defense in nitric oxide synthase I and nitric oxide synthase II knockout mice.	NOS1 NOS2	3.88e-05	2	217	2	10512307
Pubmed	[Expression of cell adhesion molecule and nitric oxide synthase in nasal mucosa in allergic rhinitis].	NOS1 NOS2	3.88e-05	2	217	2	16780147
Pubmed	Inducible-NOS but not neuronal-NOS participate in the acute effect of TNF-alpha on hypothalamic insulin-dependent inhibition of food intake.	NOS1 NOS2	3.88e-05	2	217	2	16876161
Pubmed	Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer.	MCM2 MUS81	3.88e-05	2	217	2	29393493
Pubmed	Role of nitric oxide synthase in the development of bone cancer pain and effect of L-NMMA.	NOS1 NOS2	3.88e-05	2	217	2	26648027
Pubmed	Role of UBE3A and ATP10A genes in autism susceptibility region 15q11-q13 in an Italian population: a positive replication for UBE3A.	UBE3A ATP10A	3.88e-05	2	217	2	20609483
Pubmed	VPS13C regulates phospho-Rab10-mediated lysosomal function in human dopaminergic neurons.	VPS13C RAB10	3.88e-05	2	217	2	38358348
Pubmed	Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.	NOS1 NOS2	3.88e-05	2	217	2	1379716
Pubmed	Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.	CYP4Z1 CYP4Z2P	3.88e-05	2	217	2	15059886
Pubmed	A conserved Val to Ile switch near the heme pocket of animal and bacterial nitric-oxide synthases helps determine their distinct catalytic profiles.	NOS1 NOS2	3.88e-05	2	217	2	14976216
Pubmed	Family-based association study between NOS-I and -IIA polymorphisms and autism spectrum disorders in Korean trios.	NOS1 NOS2	3.88e-05	2	217	2	18563708
Pubmed	Structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2.	MCM2 ASF1A	3.88e-05	2	217	2	26186914
Pubmed	A strategy to identify protein-N-myristoylation-dependent phosphorylation reactions of cellular proteins by using Phos-tag SDS-PAGE.	FMNL2 FMNL3	3.88e-05	2	217	2	31751425
Pubmed	A novel membrane targeting domain mediates the endosomal or Golgi localization specificity of small GTPases Rab22 and Rab31.	RAB22A RAB31	3.88e-05	2	217	2	35863437
Pubmed	The spinal cord expression of neuronal and inducible nitric oxide synthases and their contribution in the maintenance of neuropathic pain in mice.	NOS1 NOS2	3.88e-05	2	217	2	21179208
Pubmed	Spontaneous sleep in mice with targeted disruptions of neuronal or inducible nitric oxide synthase genes.	NOS1 NOS2	3.88e-05	2	217	2	12738065
Pubmed	Deficiency of iNOS does not attenuate severe congestive heart failure in mice.	NOS1 NOS2	3.88e-05	2	217	2	15319210
Pubmed	Proteomic analysis identifies ZMYM2 as endogenous binding partner of TBX18 protein in 293 and A549 cells.	ZMYM2 TBX18	3.88e-05	2	217	2	34935912
Pubmed	Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder.	NOS1 NOS2	3.88e-05	2	217	2	20888049
Pubmed	Mechanistic studies on the intramolecular one-electron transfer between the two flavins in the human neuronal nitric-oxide synthase and inducible nitric-oxide synthase flavin domains.	NOS1 NOS2	3.88e-05	2	217	2	12777376
Pubmed	Structural insight into how the human helicase subunit MCM2 may act as a histone chaperone together with ASF1 at the replication fork.	MCM2 ASF1A	3.88e-05	2	217	2	25618846
Pubmed	Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.	NOS1 NOS2	3.88e-05	2	217	2	10581083
Pubmed	Functional variants in NOS1 and NOS2A are not associated with progressive hearing loss in Ménière's disease in a European Caucasian population.	NOS1 NOS2	3.88e-05	2	217	2	21612410
Pubmed	Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.	NOS1 NOS2	3.88e-05	2	217	2	28800639
Pubmed	Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study.	NOS1 NOS2	3.88e-05	2	217	2	12490535
Pubmed	Intra- and inter-molecular effects of a conserved arginine residue of neuronal and inducible nitric oxide synthases on FMN and calmodulin binding.	NOS1 NOS2	3.88e-05	2	217	2	23507581
Pubmed	Nitric oxide mediates selective degeneration of hypothalamic orexin neurons through dysfunction of protein disulfide isomerase.	NOS1 NOS2	3.88e-05	2	217	2	23904594
Pubmed	Determinants for degradation of SAMHD1, Mus81 and induction of G2 arrest in HIV-1 Vpr and SIVagm Vpr.	DCAF1 MUS81	3.88e-05	2	217	2	25618414
Pubmed	Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates.	PPARD EP300	3.88e-05	2	217	2	10567538
Pubmed	Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis.	NOS1 NOS2	3.88e-05	2	217	2	14660484
Pubmed	Role of inducible or neuronal nitric oxide synthase in neurogenesis of the dentate gyrus in aged mice.	NOS1 NOS2	3.88e-05	2	217	2	21082337
Pubmed	Pyroptotic and apoptotic cell death in iNOS and nNOS overexpressing K562 cells: A mechanistic insight.	NOS1 NOS2	3.88e-05	2	217	2	31881190
Pubmed	Inducible nitric oxide synthase is involved in acid-induced gastric hyperemia in rats and mice.	NOS1 NOS2	3.88e-05	2	217	2	12646421
Pubmed	The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.	CYP4Z1 CYP4Z2P	3.88e-05	2	217	2	25701119
Pubmed	Up-Regulation of Human Inducible Nitric Oxide Synthase by p300 Transcriptional Complex.	NOS2 EP300	3.88e-05	2	217	2	26751080
Pubmed	Chronic alcohol consumption induces an overproduction of NO by nNOS- and iNOS-expressing myenteric neurons in the murine small intestine.	NOS1 NOS2	3.88e-05	2	217	2	21470341
Pubmed	Nitric oxide synthases: roles, tolls, and controls.	NOS1 NOS2	3.88e-05	2	217	2	7522969
Pubmed	Contribution of inducible and neuronal nitric oxide synthases to mitochondrial damage and melatonin rescue in LPS-treated mice.	NOS1 NOS2	3.88e-05	2	217	2	28110436
Pubmed	Atlas of quantitative single-base-resolution N6-methyl-adenine methylomes.	FTO PCIF1	3.88e-05	2	217	2	31822664
Pubmed	Influenza virus-induced sleep responses in mice with targeted disruptions in neuronal or inducible nitric oxide synthases.	NOS1 NOS2	3.88e-05	2	217	2	15220315
Pubmed	Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung.	HSD17B13 HSD17B11	3.88e-05	2	217	2	11165019
Pubmed	FMNL formins boost lamellipodial force generation.	FMNL2 FMNL3	3.88e-05	2	217	2	28327544
Pubmed	Protein N-myristoylation is required for cellular morphological changes induced by two formin family proteins, FMNL2 and FMNL3.	FMNL2 FMNL3	3.88e-05	2	217	2	22790947
Pubmed	Role of different nitric oxide synthase isoforms in a murine model of acute lung injury and sepsis.	NOS1 NOS2	3.88e-05	2	217	2	20655878
Pubmed	Role of Nitric Oxide in Stress-Induced Anxiety: From Pathophysiology to Therapeutic Target.	NOS1 NOS2	3.88e-05	2	217	2	28061969
Pubmed	Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line.	NOS1 NOS2	3.88e-05	2	217	2	1372907
Pubmed	Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression.	LIPG LIPE	3.88e-05	2	217	2	16940551
Pubmed	Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.	NOS1 NOS2	3.88e-05	2	217	2	17328085
Pubmed	Increased nitric oxide caused by the ketogenic diet reduces the onset time of kainic acid-induced seizures in ICR mice.	NOS1 NOS2	3.88e-05	2	217	2	16460714
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DCAF1 MIS18BP1 MYO9A GART MCM2 CHD1 CMAS DDX5 DST MDN1 PSME4 UBE3A GLYR1 DDX60L GOT2 PLEKHG4 POLE UBR4 DGKD WDR59 TANC1 AQR	4.36e-05	1353	217	22	29467282
Pubmed	A protein interaction landscape of breast cancer.	DCAF1 DOCK4 GBF1 TRIO SPTBN2 CMAS DST MDN1 XPO5 ARHGAP21 UBR4 MYO18A LARP7 CSNK2A2	5.04e-05	634	217	14	34591612
Pubmed	The ins and outs of HIV-1 Tat.	NFKBIA PLCD4 EP300	5.06e-05	12	217	3	21951552
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	FNBP1 VPS13C CYP20A1 PIGG XPO5 ARHGAP21 RAB27B GOT2 UXS1 SYNE1 MYO18A DGKD TBC1D8 ORMDL1 LRBA	5.16e-05	719	217	15	35337019
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	TRIO CHD1 DST PSME4 UBE3A SUPT6H UBR4 ANKRD13A	6.02e-05	212	217	8	33853758
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	KIF18A MIS18BP1 CMAS RAB10 DST GLYR1 CPVL ASF1A MUS81 LARP7 CSNK2A2 DZIP3 LRBA EP300	6.05e-05	645	217	14	25281560
Pubmed	A Y2H-seq approach defines the human protein methyltransferase interactome.	ETV3 ZKSCAN5 INTS2 GLYR1 CALU SLFN12 UBA3 PPARD LARP7 SAMD3	6.37e-05	342	217	10	23455924
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	TRIO CHD1 CMAS PRAG1 PHKA2 DST MSMO1 INTS2 DDX60L ARHGAP21 ATG16L2 TANK SLC30A6 CSNK2A2 STK33 IRAK3 EP300	6.42e-05	910	217	17	36736316
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	TYK2 PHKA2 RAB10 TMEM62 DST PSME4 ARHGAP21 ARHGEF28 POLE YTHDC2 ELP2 TANC1 HSD17B11 AQR	6.57e-05	650	217	14	38777146
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	PDE4D TRIO SPTBN2 PRAG1 RAB10 SYNE1 CSNK2A2 PRKCE CEP170B	7.44e-05	281	217	9	28706196
Pubmed	Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.	CYP24A1 CYP20A1 CYP4V2 CYP4Z1 CYP4Z2P	7.86e-05	70	217	5	15128046
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	KIF18A MIS18BP1 ZMYM2 CHD1 KBTBD7 MDN1 SUPT6H MUS81	8.30e-05	222	217	8	37071664
Pubmed	A conserved acetylation switch enables pharmacological control of tubby-like protein stability.	KBTBD7 PHKA2 FTO LARP7 CSNK2A2 UBXN7 TUBE1 EP300	8.57e-05	223	217	8	33187986
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	PPRC1 VPS13C GART DDX5 XPO5 SUPT6H GLYR1 ARHGAP21 DYNC2H1 SYNE1 MYO18A APOB CASP12 EP300 INPP5J	8.76e-05	754	217	15	35906200
Interaction	DUS3L interactions	SSB XPO5 CALU MUS81 LARP7 DPP9 EP300	1.87e-06	56	211	7	int:DUS3L
Interaction	TOP3B interactions	GBF1 TRIO PPRC1 MYO10 LONRF1 SPTBN2 PIGG PRAG1 TYK2 DST MDN1 PSME4 XPO5 RAB43 CPVL ARHGAP21 RARG POLE KHNYN UBR4 MUS81 APOB CDC14A WDR59 CELSR2 RBMX2 CHD5 KDM4A TANC1 LRBA IL17RD LSM10 EP300 CEP170B	1.03e-05	1470	211	34	int:TOP3B
GeneFamily	RAB, member RAS oncogene GTPases	RAB8B RAB22A RAB10 RAB43 RAB27B RAB31	1.63e-05	65	150	6	388
Coexpression	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP	FOXRED2 CAPN5 ARHGAP21 DENND5B RAB31 MYO18A FMNL3 LIPE IRAK3 PRKCE FILIP1L	8.74e-07	199	216	11	M7156
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	MYO10 SPTBN2 TYK2 SV2A KHK NPTX1 PPARD CELSR2 MYOM2 PRAME EP300 AQR	3.44e-06	276	216	12	M3063
Coexpression	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	FNBP1 PDE4D SPOCK1 CYP24A1 GART ERMP1 PRAG1 FAT2 GLYR1 TMEM245 RAB43 TMEM178B RAB27B NPTX1 RAB31 SLC16A14 HSD17B11 EP300	7.91e-06	648	216	18	M14371
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	DOCK4 SPOCK1 FMNL2 DST TMEM245 CMAHP DYNC2H1 ATP10A CDC14A TANC1	1.13e-05	212	216	10	M39221
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	TRIO MYO9A VPS13C PITPNC1 DDX5 ARHGEF28 PRKCE LRBA IMMP2L	1.19e-05	169	216	9	M39230
Coexpression	GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP	ADPRH GLYR1 GOT2 ATG16L2 SYNE1 TBC1D8 ORMDL1 MYO1F IRAK3	4.48e-05	200	216	9	M7295
Coexpression	GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP	PSME4 SV2A CMAHP CPVL UBR4 YTHDC2 CDC14A SLC30A6 EP300	4.48e-05	200	216	9	M9889
Coexpression	GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN	DCAF1 PNMA1 PIGG NFKBIA RABGGTA EDC3 PPM1D MUS81 MINDY2	4.48e-05	200	216	9	M7334
Coexpression	DELACROIX_RARG_BOUND_MEF	GAS8 PITPNC1 DDX5 TYK2 OLFML2A DST CAPN5 RARG OTUD5 CALU LIPE DPP9	5.67e-05	366	216	12	M2461
CoexpressionAtlas	Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3	LONRF1 SERPINF1 FMNL2 FOXRED2 DST FGD4 SYDE2 ENPP5 CAPN5 PLSCR3 RAB31 ANKRD13A CASP12 IRAK3 PRKCE	2.46e-05	423	212	15	GSM399454_500
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	DCAF1 EFCAB5 KIF18A MIS18BP1 MYO10 SPTBN2 ZMYM2 MCM2 CHD1 FMNL2 IL18R1 BRWD3 PSME4 FGD4 DNASE1L1 ARHGAP21 CCDC40 LARGE2 PLEKHG4 OTUD5 DYNC2H1 ZDBF2 ATP10A CDC14A LARP7 ORMDL1 CELSR2 RBMX2 IL17RD IMMP2L	4.21e-05	1370	212	30	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	DCAF1 EFCAB5 KIF18A PDE4D MIS18BP1 SERPINF1 ZMYM2 CHD1 SSB PITPNC1 IL18R1 BRWD3 MDN1 PSME4 MSMO1 CMAHP CCDC40 DENND5B RASA1 PPM1D POLE NTS CDC14A FUT11 ORMDL1 DZIP3 LRBA FILIP1L	5.40e-05	1252	212	28	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1	MYOM1 TRIO SERPINF1 FMNL2 DST FGD4 SYDE2 ENPP5 PLSCR3 RAB27B TBC1D8 CASP12 IRAK3 PRKCE	6.72e-05	409	212	14	GSM476663_500
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOCK4 FNBP1 PDE4D TRIO PITPNC1 FMNL2 FGD4 RASA1 PPARD PRKCE LRBA IMMP2L	2.25e-10	193	218	12	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK4 PDE4D TRIO MYO9A FGD4 FTO PRKCE TANC1 LRBA IMMP2L	5.32e-08	198	218	10	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	PSB\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TEKT3 CATSPERD SERPINF1 CHST9 MSMO1 COL21A1 ENPP5 DYNC2H1 STK33 TTC29	5.32e-08	198	218	10	4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 MYOM1 SPOCK1 IL18R1 COL21A1 SYNE1 OVCH1 ATP10A SAMD3	3.75e-07	187	218	9	15d6e158562d7d85af3ceaf955439b379c8fce81
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 MYOM1 SPOCK1 IL18R1 COL21A1 SYNE1 OVCH1 ATP10A SAMD3	3.75e-07	187	218	9	f62074b631fd45ad299c69d71b09267b04d656ee
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 MYOM1 SPOCK1 IL18R1 COL21A1 SYNE1 OVCH1 ATP10A SAMD3	3.92e-07	188	218	9	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	Monocytes-Tissue-resident_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	DOCK4 SERPINF1 B3GNT6 DST FGD4 RAB31 TLR5 IRAK3 FILIP1L	4.29e-07	190	218	9	07215e8f292cb54c670037aaf28393cddbe5548c
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	UAP1 SPOCK1 RAB8B SERPINF1 FMNL2 COL6A3 TANK CYP4Z1 DYNC2H1	4.68e-07	192	218	9	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	UAP1 SPOCK1 RAB8B SERPINF1 PITPNC1 FMNL2 PDZRN4 COL6A3 TANK	5.11e-07	194	218	9	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D TRIO FGD4 LIPG RARG MINDY2 ANKRD13A IMMP2L SLC14A2	5.11e-07	194	218	9	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK4 PDE4D MYO10 DST TMEM178B RAB27B COL6A3 IRAK3 TANC1	5.11e-07	194	218	9	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D TRIO FGD4 LIPG RARG MINDY2 ANKRD13A IMMP2L SLC14A2	5.11e-07	194	218	9	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAB8B ADAM8 FGD4 DDX60L ATG16L2 ALPK1 MYO1F TNFAIP6 HSD17B11	5.57e-07	196	218	9	fe8d3f45a64323947c36b127355d5940eb56c0ca
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAB8B ADAM8 FGD4 DDX60L ATG16L2 ALPK1 MYO1F TNFAIP6 HSD17B11	5.57e-07	196	218	9	526d037bb12d81f1c235c60ddc787fbad0bbad77
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK4 PDE4D MYO10 DST COL21A1 TMEM178B RAB27B COL6A3 IRAK3	5.81e-07	197	218	9	31a1852911bda38543916585fda34255fd62a134
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAB8B CHD1 ADAM8 FGD4 DDX60L ATG16L2 MYO1F TNFAIP6 HSD17B11	5.81e-07	197	218	9	3cd1c816bc7a57278b2ef615b69545356ab8f522
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAB8B CHD1 ADAM8 NFKBIA DDX60L ATG16L2 MYO1F IRAK3 TNFAIP6	6.32e-07	199	218	9	9da8b48ec1c1c105fcbab6ae8f08166e7d5e8a35
ToppCell	(53)_Lymphoid_DC\|World / shred on Cell_type and subtype	SERPINF1 FMNL2 NOS1 ARHGAP21 NTS TBC1D8 PRAME INPP5J FILIP1L	9.14e-07	208	218	9	30212cfacad94a7cc562a69efa73a31259851515
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ADPRH FOXRED2 CAPN5 PLEKHG4 KHNYN LARP7 TLR5 TNFAIP6	9.50e-07	154	218	8	1c62290a2558fd6401b27de5a867d243b143b00a
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TEKT3 ODAD1 FTO CCDC40 DYNC2H1 C16orf96 STK33 TTC29	1.91e-06	169	218	8	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SPOCK1 MYO9A CHST9 ERMP1 LIPG CPVL MINDY2 IMMP2L	2.81e-06	178	218	8	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TNIP1 FGD4 NFKBIA RAB31 TANK MYO1F IRAK3 TNFAIP6	3.32e-06	182	218	8	243c783675df495ea4112dbf710712c44ea6b4f1
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TNIP1 FGD4 NFKBIA RAB31 TANK MYO1F IRAK3 TNFAIP6	3.32e-06	182	218	8	18790a394dc32b3cef99cdbf826392c520e38b4a
ToppCell	normal_Lung-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	FNBP1 SERPINF1 ETV3 ADAM8 NOS1 LINC00158 TBC1D8 PRAME	3.89e-06	186	218	8	00ad1239b952119b3fd2e6af8f034cba3488f9c1
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PDE4D MYO10 PITPNC1 PDZRN4 DGKD CDC14A TANC1 IL17RD	4.21e-06	188	218	8	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK4 MYO10 OLFML2A DST COL21A1 COL6A3 DYNC2H1 HMCN1	4.38e-06	189	218	8	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 MYO10 FMNL2 FGD4 TBC1D8 PRKCE LRBA SLC14A2	4.55e-06	190	218	8	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAB8B ADAM8 TECPR2 NFKBIA DDX60L TANK IRAK3 TNFAIP6	4.55e-06	190	218	8	212f0d9defcc3174e225cc3d90e7814e238794b6
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAB10 DST CMAHP COL6A3 RASA1 CALU HMCN1 FILIP1L	4.55e-06	190	218	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO PPRC1 PRAG1 FMNL2 RAB31 DGKD PPARD ATP10A	4.92e-06	192	218	8	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	DOCK4 PDE4D MYO10 DST COL21A1 COL6A3 HMCN1 TANC1	4.92e-06	192	218	8	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	normal_Lymph_Node-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	FNBP1 RAB8B ETV3 NOS1 TANK TBC1D8 TNFAIP6 PRAME	5.11e-06	193	218	8	024d30eb143d8278c0851c3a6c9426226fa3b480
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A CHST9 PRAG1 FGD4 TMEM178B SYNE1 TBC1D8 SLC15A1	5.11e-06	193	218	8	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A CHST9 PRAG1 FGD4 TMEM178B SYNE1 TBC1D8 SLC15A1	5.11e-06	193	218	8	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	UAP1 SPOCK1 RAB8B SERPINF1 COL6A3 TANK DYNC2H1 TBX18	5.11e-06	193	218	8	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A CHST9 PRAG1 FGD4 CPVL ARHGEF28 SYNE1 IMMP2L	5.31e-06	194	218	8	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ODAD1 COL21A1 CCDC40 DYNC2H1 SYNE1 STK33 TTC29 DZIP3	5.31e-06	194	218	8	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK4 MYO10 OLFML2A DST COL21A1 TMEM178B COL6A3 HMCN1	5.31e-06	194	218	8	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	CF-Myeloid\|CF / Disease state, Lineage and Cell class	DOCK4 RAB8B ADAM8 TECPR2 DDX60L MYO1F IRAK3 TNFAIP6	5.51e-06	195	218	8	ecf604de496f389a49429d0bb211e1db6019cc8b
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PDE4D MYO10 PRAG1 DST TMEM178B RAB27B COL6A3 IRAK3	5.51e-06	195	218	8	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	PDE4D CHST9 CMAHP SYNE1 CYP4Z2P STK33 TTC29 TANC1	5.72e-06	196	218	8	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAB8B ADAM8 NFKBIA DDX60L ATG16L2 MYO1F IRAK3 TNFAIP6	5.72e-06	196	218	8	d9b5eaca4089d5337f1175a663418c9c675cdd87
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	PDE4D CHST9 CMAHP SYNE1 CYP4Z2P STK33 TTC29 TANC1	5.72e-06	196	218	8	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO10 SERPINF1 DST COL21A1 COL6A3 DYNC2H1 SYNE1 ALPK1	5.94e-06	197	218	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CATSPERD ODAD1 CCDC40 DYNC2H1 SYNE1 STK33 TTC29 DZIP3	5.94e-06	197	218	8	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP9Y ERMN RAB27B ARHGEF28 SYNE1 CDC14A SAMD3 LRBA	5.94e-06	197	218	8	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAB8B ADAM8 NFKBIA DDX60L ATG16L2 MYO1F IRAK3 TNFAIP6	5.94e-06	197	218	8	037f5f26fa66818baa35846aa96336155e8a6f45
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAB8B CHD1 ADAM8 TECPR2 DDX60L MYO1F TNFAIP6 HSD17B11	5.94e-06	197	218	8	340ce4fef244176fb52e38ffbcbdfda5ac3467dd
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ODAD1 CHST9 HSD17B13 DYNC2H1 SYNE1 TBC1D8 TTC29 DZIP3	5.94e-06	197	218	8	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ODAD1 CHST9 HSD17B13 DYNC2H1 SYNE1 TBC1D8 TTC29 DZIP3	5.94e-06	197	218	8	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ODAD1 CHST9 HSD17B13 DYNC2H1 SYNE1 TBC1D8 TTC29 DZIP3	5.94e-06	197	218	8	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ODAD1 CHST9 HSD17B13 DYNC2H1 SYNE1 TBC1D8 TTC29 DZIP3	5.94e-06	197	218	8	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	NS-critical-d_0-4-Myeloid\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK4 RAB8B NFKBIA DDX60L TANK MYO1F IRAK3 TNFAIP6	6.17e-06	198	218	8	72d51284d267f102c26f0ae8279ee9e11e69c7e3
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FNBP1 RAB8B SERPINF1 ETV3 TANK LINC00158 TBC1D8 PRAME	6.17e-06	198	218	8	f4ff9520598ebc52b3a1f31eee766957983e16b4
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FNBP1 RAB8B SERPINF1 ETV3 TANK LINC00158 TBC1D8 PRAME	6.17e-06	198	218	8	c58e2d3a21fcca9f1accccc5303ca4222b6c8432
ToppCell	Mild/Remission-B_memory-3\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FNBP1 PDE4D MIS18BP1 PITPNC1 NFKBIA RAB31 CDC14A MYO1F	6.17e-06	198	218	8	44906dbf99ddd53335e2d32082ff7e77d91baaeb
ToppCell	Severe-B_memory-3\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FNBP1 PDE4D PITPNC1 NFKBIA RAB31 CDC14A ANKRD13A MYO1F	6.17e-06	198	218	8	a3050c126799e32f742a14396236572250476820
ToppCell	mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC\|mLN / shred on region, Cell_type, and subtype	SERPINF1 FMNL2 NTS TBC1D8 TNFAIP6 PRAME INPP5J FILIP1L	6.17e-06	198	218	8	da84c76afe835aeee39da04b63c03549218b5d91
ToppCell	mLN-Dendritic_cell-Lymphoid_DC\|mLN / Region, Cell class and subclass	SERPINF1 FMNL2 NTS TBC1D8 TNFAIP6 PRAME INPP5J FILIP1L	6.17e-06	198	218	8	3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92
ToppCell	Mild/Remission-B_memory-3\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FNBP1 PDE4D MIS18BP1 PITPNC1 NFKBIA RAB31 CDC14A MYO1F	6.40e-06	199	218	8	493d043beef70b60338cc199db82592cdc6e635d
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	PDE4D TRIO FMNL2 FGD4 FTO ARHGEF28 LRBA IMMP2L	6.40e-06	199	218	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DOCK4 MYO10 SERPINF1 DST COL21A1 COL6A3 DYNC2H1 SYNE1	6.40e-06	199	218	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	critical\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DOCK4 TNIP1 RAB10 NFKBIA DDX60L TANK IRAK3 TNFAIP6	6.40e-06	199	218	8	16c55cb8a0e740342009965f0eddfb0ed2858fab
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KBTBD7 FGD4 RAB31 SYNE1 ALPK1 MYO1F IRAK3 TNFAIP6	6.40e-06	199	218	8	b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DOCK4 SERPINF1 DST COL21A1 COL6A3 DYNC2H1 SYNE1 ALPK1	6.64e-06	200	218	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CATSPERD ODAD1 CCDC40 DYNC2H1 SYNE1 STK33 TTC29 DZIP3	6.64e-06	200	218	8	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KBTBD7 FGD4 RAB31 SYNE1 ALPK1 MYO1F IRAK3 TNFAIP6	6.64e-06	200	218	8	808571d74bb5c4d765ff13fc9393f88020d4e90d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 IL18R1 COL21A1 SYNE1 PRDM12 SAMD3 FILIP1L	9.32e-06	150	218	7	8645b9c7f9511ed6cc9afe04440c2873a3094150
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRD MYOM1 MYO9A RAB8B DNASE1L1 RAB31 MYO1F	1.25e-05	157	218	7	ec433d2fe827abdb647be4176c231b7052482b6f
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIO IL18R1 SYDE2 HSD17B13 DYNC2H1 SYNE1 GDF3	1.31e-05	158	218	7	12661763d1c309106801cb710c04cd2b62d16cba
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIO IL18R1 SYDE2 HSD17B13 DYNC2H1 SYNE1 GDF3	1.31e-05	158	218	7	0792c39e6fc0745095af7812de2d50949540d60f
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIO IL18R1 SYDE2 HSD17B13 DYNC2H1 SYNE1 GDF3	1.31e-05	158	218	7	e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72
ToppCell	Basal_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	CYP24A1 SERPINF1 CHST9 OLFML2A HSD17B13 NTS APOB	1.60e-05	163	218	7	679e25e5548d157d49a73057a3b5617dccda260f
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	CATSPERD ODAD1 CHST9 COL21A1 HSD17B13 TTC29 INPP5J	1.73e-05	165	218	7	731147b4337fd0de4383dc8170b4f9ccd98caec6
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM8 IL18R1 SYNE1 YIPF7 SLC16A14 MYOM2 SAMD3	1.73e-05	165	218	7	eeb58d4db64ad37dc6b441eab22b05c24862e1a9
ToppCell	TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-9\|TCGA-Colorectal / Sample_Type by Project: Shred V9	MYOM1 COL21A1 NOS1 PDZRN4 NPTX1 PLCD4 KY	1.80e-05	166	218	7	68e6fc7c0040bbe48a93f96ecf28afffdc626845
ToppCell	Basal_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	CYP24A1 SERPINF1 CHST9 FAT2 DST LARGE2 CELSR2	1.94e-05	168	218	7	48089fa2d4a0f31a72405717119b767a92571f01
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 SPOCK1 PITPNC1 COL21A1 PDZRN4 ATP10A MYOM2	2.10e-05	170	218	7	cdb6fad277f284c3fd5a6f45672a8edc24715882
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 SPOCK1 PITPNC1 COL21A1 PDZRN4 ATP10A MYOM2	2.10e-05	170	218	7	99dd734c0972a40d5381e8e2d96bdaa31f6d06e6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 SPOCK1 PITPNC1 COL21A1 PDZRN4 ATP10A MYOM2	2.10e-05	170	218	7	3a14eeae221b8bb0bd0dadcb8e7a603431240a1e
ToppCell	wk_15-18-Hematologic-Myeloid-aDC_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FNBP1 RAB8B ETV3 NOS1 LINC00158 TBC1D8 PRAME	2.72e-05	177	218	7	ccf5dc54780d6039a4d062dee88440c011ddc0a3
ToppCell	Club_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	HSD17B13 LARGE2 NPTX1 NTS MYO18A HMCN1	2.79e-05	120	218	6	7f85208f0455f3e634f8e7e81beea60b4ef1d2a5
ToppCell	LPS-antiTNF-Myeloid-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 TNIP1 NFKBIA RAB31 TANK IRAK3 TNFAIP6	2.82e-05	178	218	7	bd689205bc92cda5f71df64c2332ff76adcd84b4
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 VPS13C CHD1 DDX5 SYNE1 SLFN12 FILIP1L	2.82e-05	178	218	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	LPS-antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 TNIP1 NFKBIA RAB31 TANK IRAK3 TNFAIP6	2.82e-05	178	218	7	afcc92e8fe313c85eaf617cf4dbc3058da6c99d6
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPVL PDZRN4 NPTX1 ATP10A CDC14A MYOM2 SAMD3	2.82e-05	178	218	7	a62137d7f5fac16619f8a02844cdb0be7a794bf2
ToppCell	Severe-B_memory-3\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FNBP1 PDE4D PITPNC1 NFKBIA RAB31 CDC14A MYO1F	3.03e-05	180	218	7	90b812c5450359b1745b413421b71e291c97086a
ToppCell	LPS_only-Myeloid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FGD4 NFKBIA RAB31 TANK MYO1F IRAK3 TNFAIP6	3.25e-05	182	218	7	666ac86ee5f6fa9241ae8d80340743707e54b278
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	USP9Y IL18R1 NOS2 SLFN12 HMCN1	3.34e-05	75	218	5	70c346f92a9ac7e33fc1b9dee1dca0bf9ae0a38c
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	USP9Y IL18R1 NOS2 SLFN12 HMCN1	3.34e-05	75	218	5	3167beedef7304697e9577270cdeacfc9743cee1
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	USP9Y IL18R1 NOS2 SLFN12 HMCN1	3.34e-05	75	218	5	26d6e54ed0a6c3ff57f6269c460177bc7b8bf979
ToppCell	PND10-Immune-Immune_Myeloid-Dendritic-cDC1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRIO SERPINF1 ZKSCAN5 RAB43 POLE TBC1D8 LRBA	3.36e-05	183	218	7	ab38264daddccdf5ffb75ff2210b27423eca6bc0
ToppCell	PND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRIO SERPINF1 ZKSCAN5 RAB43 POLE TBC1D8 LRBA	3.36e-05	183	218	7	263bfa1d8a7314bc3156c735c403c3bab8ea4dac
ToppCell	PND10-Immune-Immune_Myeloid-Dendritic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRIO SERPINF1 ZKSCAN5 RAB43 POLE TBC1D8 LRBA	3.36e-05	183	218	7	e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 TNIP1 IL18R1 NFKBIA DDX60L RAB31 IRAK3	3.48e-05	184	218	7	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO PITPNC1 PRAG1 DST TMEM178B ATP10A CDC14A	3.48e-05	184	218	7	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	(7)_DC_activated\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SERPINF1 FMNL2 NOS1 ARHGAP21 NPTX1 TBC1D8 PRAME	3.48e-05	184	218	7	b89871a3e36fde6daa68daf116f8c8d587554c0f
ToppCell	LPS-IL1RA-Myeloid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FGD4 NFKBIA RAB31 TANK MYO1F IRAK3 TNFAIP6	3.60e-05	185	218	7	9b5fd87ea9d05e051ff1251578ecfbe5e8652853
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CATSPERD ODAD1 CHST9 COL21A1 DYNC2H1 STK33 DZIP3	3.60e-05	185	218	7	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes\|lymph-node_spleen / Manually curated celltypes from each tissue	DOCK4 FMNL2 FGD4 CPVL RAB31 TBC1D8 IRAK3	3.73e-05	186	218	7	d7da5edb2ee36f96cdd7e27eb9afcc1cbfd52bb6
Disease	melioidosis (is_marker_for)	SERPINF1 TLR5 IRAK3	7.10e-06	6	211	3	DOID:5052 (is_marker_for)
Disease	sciatic neuropathy (implicated_via_orthology)	BDKRB1 NFKBIA FTO CASP12	2.02e-05	23	211	4	DOID:11446 (implicated_via_orthology)
Disease	biliary tract cancer (is_marker_for)	APOB PPARD	5.09e-05	2	211	2	DOID:4607 (is_marker_for)
Disease	retinopathy of prematurity (biomarker_via_orthology)	SERPINF1 NOS1 NOS2	7.56e-05	12	211	3	DOID:13025 (biomarker_via_orthology)
Disease	free cholesterol to total lipids in large VLDL percentage	LIPG APOB CELSR2 PCIF1	1.39e-04	37	211	4	EFO_0022281
Disease	hematological measurement, pulmonary function measurement, blood pressure, grip strength measurement, lipoprotein measurement, vital capacity	FNBP1 TRIO	1.52e-04	3	211	2	EFO_0003892, EFO_0004312, EFO_0004325, EFO_0004503, EFO_0004732, EFO_0006941
Disease	ovary adenocarcinoma (is_marker_for)	CYP24A1 PRAME	1.52e-04	3	211	2	DOID:3713 (is_marker_for)
Disease	cholesterol in very small VLDL measurement	LIPG APOB CELSR2 PCIF1	1.90e-04	40	211	4	EFO_0022231
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOB CELSR2 PCIF1	2.28e-04	17	211	3	EFO_0022232
Disease	sleep duration, high density lipoprotein cholesterol measurement	LIPG RAB43 APOB KY CELSR2 PCIF1	2.42e-04	121	211	6	EFO_0004612, EFO_0005271
Disease	cardiac troponin I measurement	PDE4D MYO10 CYP4V2 OVCH1 FMNL3 CASP12 SLC14A2	2.87e-04	176	211	7	EFO_0010071
Disease	corneal neovascularization (is_implicated_in)	SERPINF1 TNFAIP6	3.02e-04	4	211	2	DOID:11382 (is_implicated_in)
Disease	Dyggve-Melchior-Clausen disease (implicated_via_orthology)	RAB8B RAB10	3.02e-04	4	211	2	DOID:0111167 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	APOB CELSR2 PCIF1	4.36e-04	21	211	3	EFO_0022246
Disease	Smith-McCort dysplasia (implicated_via_orthology)	RAB8B RAB10	5.02e-04	5	211	2	DOID:0060247 (implicated_via_orthology)
Disease	ras-related protein Rab-22A measurement	RAB22A RAB31	5.02e-04	5	211	2	EFO_0802991
Disease	phospholipids in IDL measurement	LIPG APOB CELSR2 PCIF1	5.26e-04	52	211	4	EFO_0022164
Disease	vital capacity	SPTBN2 DDX5 DST COL21A1 TMEM178B VWA5B1 COL6A3 RARG SYNE1 C16orf96 APOB LARP7 TBX18 KY HMCN1 UBXN7 MYO1F LRBA SLC14A2 FILIP1L	6.00e-04	1236	211	20	EFO_0004312
Disease	triglycerides in medium HDL measurement	LIPG APOB CELSR2 PCIF1	6.07e-04	54	211	4	EFO_0022321
Disease	nighttime rest measurement	MYOM1 MYO18A TANC1	6.53e-04	24	211	3	EFO_0007827
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	SERPINF1 FTO NOS1 NOS2 CASP12 PRKCE	6.82e-04	147	211	6	DOID:9352 (biomarker_via_orthology)
Disease	Psoriasis	TNIP1 TYK2 NFKBIA NOS2	7.46e-04	57	211	4	C0033860
Disease	Pustulosis of Palms and Soles	TNIP1 TYK2 NFKBIA NOS2	7.46e-04	57	211	4	C0030246
Disease	diabetic angiopathy (implicated_via_orthology)	BDKRB1 NOS2	7.49e-04	6	211	2	DOID:11713 (implicated_via_orthology)
Disease	cholesterol to total lipids in small LDL percentage	LIPG APOB PCIF1	9.29e-04	27	211	3	EFO_0022241
Disease	cholesterol to total lipids in medium LDL percentage	LIPG APOB PCIF1	9.29e-04	27	211	3	EFO_0022238
Disease	phospholipids in HDL measurement	LIPG APOB CELSR2 PCIF1	9.64e-04	61	211	4	EFO_0022293
Disease	LDL cholesterol change measurement	APOB CELSR2	1.04e-03	7	211	2	EFO_0007804
Disease	Hyperammonemia	GOT2 TLR5	1.04e-03	7	211	2	C0220994
Disease	10-undecenoate 11:1n1 measurement	CYP4Z1 CYP4Z2P	1.04e-03	7	211	2	EFO_0021099
Disease	focal segmental glomerulosclerosis (implicated_via_orthology)	MYO9A CMAS	1.04e-03	7	211	2	DOID:1312 (implicated_via_orthology)
Disease	selenium measurement	PITPNC1 DYNC2H1 MYOM2	1.15e-03	29	211	3	EFO_0006331
Disease	respiratory failure, COVID-19	TYK2 DST DPP9	1.15e-03	29	211	3	EFO_0009686, MONDO_0100096
Disease	epilepsy (implicated_via_orthology)	TRIO BDKRB1 UBE3A SV2A NOS1 NOS2	1.17e-03	163	211	6	DOID:1826 (implicated_via_orthology)
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	APOB CELSR2	1.39e-03	8	211	2	EFO_0008589, EFO_0008595
Disease	cholesterol to total lipids in very large HDL percentage	LIPG CELSR2 PCIF1	1.40e-03	31	211	3	EFO_0022243
Disease	blood urea nitrogen measurement	CYP24A1 PITPNC1 FTO PPM1D PLCD4 CDC14A SLC15A1 TANC1 LRBA SLC14A2	1.63e-03	452	211	10	EFO_0004741
Disease	sugar consumption measurement	TRIO FTO TANK STK33 SLC14A2	1.75e-03	120	211	5	EFO_0010158
Disease	Silicosis	NOS2 PDZRN4	1.77e-03	9	211	2	C0037116
Disease	C-reactive protein measurement, high density lipoprotein cholesterol measurement	FTO CELSR2 PCIF1	1.83e-03	34	211	3	EFO_0004458, EFO_0004612
Disease	chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	APOB CELSR2 PCIF1	1.83e-03	34	211	3	EFO_0008317, EFO_0008596, EFO_0020947
Disease	Malignant neoplasm of breast	CATSPERE CYP24A1 TNIP1 PKDREJ NFKBIA FTO NOS2 TANK RARG DYNC2H1 PPM1D SYNE1 UBR4 LIPE CHD5 LRBA EP300	1.94e-03	1074	211	17	C0006142
Disease	Kartagener Syndrome	ODAD1 GAS8 CCDC40	1.99e-03	35	211	3	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	ODAD1 GAS8 CCDC40	1.99e-03	35	211	3	C4551906
Disease	Polynesian Bronchiectasis	ODAD1 GAS8 CCDC40	1.99e-03	35	211	3	C4317124
Disease	psoriasis, type 2 diabetes mellitus	TNIP1 TYK2 FTO NOS2	2.08e-03	75	211	4	EFO_0000676, MONDO_0005148
Disease	angina pectoris	BRWD3 CMAHP DYNC2H1 APOB CELSR2	2.09e-03	125	211	5	EFO_0003913
Disease	melanoma	FTO ASF1A UBR4 PPARD KDM4A PRAME EP300	2.13e-03	248	211	7	C0025202
Disease	Primary ciliary dyskinesia	ODAD1 GAS8 CCDC40	2.16e-03	36	211	3	cv:C0008780
Disease	cholesteryl esters to total lipids in very large HDL percentage	APOB CELSR2 PCIF1	2.16e-03	36	211	3	EFO_0022257
Disease	triglycerides to total lipids in large VLDL percentage	APOB CELSR2 PCIF1	2.73e-03	39	211	3	EFO_0022332
Disease	degree of unsaturation measurement	LIPG APOB PCIF1	2.73e-03	39	211	3	EFO_0022261
Disease	Allodynia	BDKRB1 NOS1 NOS2 PRKCE	3.14e-03	84	211	4	C0458247
Disease	Mechanical Allodynia	BDKRB1 NOS1 NOS2 PRKCE	3.14e-03	84	211	4	C2936719
Disease	Hyperalgesia, Secondary	BDKRB1 NOS1 NOS2 PRKCE	3.14e-03	84	211	4	C0751212
Disease	Hyperalgesia, Primary	BDKRB1 NOS1 NOS2 PRKCE	3.14e-03	84	211	4	C0751211
Disease	Hyperalgesia, Thermal	BDKRB1 NOS1 NOS2 PRKCE	3.14e-03	84	211	4	C0751214
Disease	Tactile Allodynia	BDKRB1 NOS1 NOS2 PRKCE	3.14e-03	84	211	4	C0751213
Disease	Hyperalgesia	BDKRB1 NOS1 NOS2 PRKCE	3.14e-03	84	211	4	C0020429
Disease	collagen disease (implicated_via_orthology)	NFKBIA TLR5	3.20e-03	12	211	2	DOID:854 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in small LDL percentage	LIPG APOB PCIF1	3.37e-03	42	211	3	EFO_0022255
Disease	triglycerides in large LDL measurement	APOB CELSR2 PCIF1	3.60e-03	43	211	3	EFO_0022319
Disease	cholesteryl esters to total lipids in small HDL percentage	LIPG APOB CELSR2	3.60e-03	43	211	3	EFO_0022254
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB CELSR2 PCIF1	3.60e-03	43	211	3	EFO_0022290
Disease	pleurisy (implicated_via_orthology)	BDKRB1 NOS2	3.77e-03	13	211	2	DOID:10247 (implicated_via_orthology)
Disease	pulmonary emphysema (implicated_via_orthology)	NFKBIA MUS81	3.77e-03	13	211	2	DOID:9675 (implicated_via_orthology)
Disease	Diabetes, Autoimmune	TYK2 NOS1 CASP12	3.85e-03	44	211	3	C0205734
Disease	Brittle diabetes	TYK2 NOS1 CASP12	3.85e-03	44	211	3	C0342302
Disease	Diabetes Mellitus, Sudden-Onset	TYK2 NOS1 CASP12	3.85e-03	44	211	3	C4554117
Disease	Diabetes Mellitus, Ketosis-Prone	TYK2 NOS1 CASP12	3.85e-03	44	211	3	C3837958
Disease	respiratory system disease	DCAF1 CYP20A1 ERMP1 IL18R1 NFKBIA	3.96e-03	145	211	5	EFO_0000684
Disease	lipid measurement, lipoprotein measurement	LIPG APOB PPARD CELSR2	4.02e-03	90	211	4	EFO_0004529, EFO_0004732
Disease	total lipids in very small VLDL measurement	LIPG APOB CELSR2	4.10e-03	45	211	3	EFO_0022156
Disease	Diabetes Mellitus, Insulin-Dependent	TYK2 NOS1 CASP12	4.10e-03	45	211	3	C0011854
Disease	diabetic retinopathy (biomarker_via_orthology)	SERPINF1 BDKRB1 NOS1	4.10e-03	45	211	3	DOID:8947 (biomarker_via_orthology)
Disease	obesity (biomarker_via_orthology)	SERPINF1 FTO NOS1 GOT2 LIPE	4.19e-03	147	211	5	DOID:9970 (biomarker_via_orthology)
Disease	psychosis	COL21A1 CPVL	4.38e-03	14	211	2	EFO_0005407
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB CELSR2	4.38e-03	14	211	2	EFO_0004611, EFO_0008589
Disease	free cholesterol in very small VLDL measurement	APOB CELSR2 PCIF1	4.64e-03	47	211	3	EFO_0022275
Disease	Primary Ciliary Dyskinesia	ODAD1 GAS8 CCDC40	4.64e-03	47	211	3	C4551720
Disease	Mammary Carcinoma, Human	CYP24A1 TNIP1 NFKBIA FTO NOS2 TANK DYNC2H1 PPM1D SYNE1 EP300	4.74e-03	525	211	10	C4704874
Disease	Mammary Neoplasms, Human	CYP24A1 TNIP1 NFKBIA FTO NOS2 TANK DYNC2H1 PPM1D SYNE1 EP300	4.74e-03	525	211	10	C1257931
Disease	testosterone measurement	DOCK4 KIF18A CYP24A1 ZNF275 PKDREJ ZKSCAN5 TYK2 SV2A HSD17B13 PLSCR3 FTO ARHGAP21 CCDC73 C16orf96 SLC30A6 TBC1D8 LIPE HMCN1	4.83e-03	1275	211	18	EFO_0004908
Disease	Mammary Neoplasms	CYP24A1 TNIP1 NFKBIA FTO NOS2 TANK DYNC2H1 PPM1D SYNE1 EP300	4.87e-03	527	211	10	C1458155
Disease	total lipids in lipoprotein particles measurement	LIPG APOB CELSR2	4.92e-03	48	211	3	EFO_0022309
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	LIPG ATG16L2 APOB CELSR2 PCIF1	4.96e-03	153	211	5	EFO_0004611, EFO_0020946
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	APOB PCIF1	5.03e-03	15	211	2	EFO_0022328
Disease	Hypertriglyceridemia	APOB CELSR2	5.03e-03	15	211	2	C0020557
Disease	response to statin, LDL cholesterol change measurement	APOB CELSR2	5.03e-03	15	211	2	EFO_0007804, GO_0036273
Disease	hepatic encephalopathy (biomarker_via_orthology)	NOS1 NOS2	5.03e-03	15	211	2	DOID:13413 (biomarker_via_orthology)
Disease	lipid measurement, intermediate density lipoprotein measurement	LIPG APOB CELSR2 PCIF1	5.06e-03	96	211	4	EFO_0004529, EFO_0008595
Disease	phospholipids in medium LDL measurement	APOB CELSR2 PCIF1	5.21e-03	49	211	3	EFO_0022183
Disease	apolipoprotein B to apolipoprotein A1 ratio	LIPG APOB CELSR2	5.21e-03	49	211	3	EFO_0021897
Disease	cholesterol in medium LDL measurement	APOB CELSR2 PCIF1	5.21e-03	49	211	3	EFO_0022224
Disease	cholesterol in small LDL measurement	APOB CELSR2 PCIF1	5.21e-03	49	211	3	EFO_0022227
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	LIPG APOB CELSR2 CSNK2A2 PCIF1 LRBA	5.40e-03	222	211	6	EFO_0008317, EFO_0020943
Disease	Breast Carcinoma	CYP24A1 TNIP1 NFKBIA FTO NOS2 TANK DYNC2H1 PPM1D SYNE1 EP300	5.61e-03	538	211	10	C0678222
Disease	total cholesterol measurement, intermediate density lipoprotein measurement	LIPG APOB CELSR2 PCIF1	5.64e-03	99	211	4	EFO_0004574, EFO_0008595
Disease	cutaneous psoriasis measurement, psoriasis	TNIP1 NOS2	5.72e-03	16	211	2	EFO_0000676, EFO_0007773
Disease	endometriosis (biomarker_via_orthology)	SERPINF1 NFKBIA	5.72e-03	16	211	2	DOID:289 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KRNVEHWIGHENFEL	UXS1	126	Q8NBZ7
KEQLGSRQHEVEWQT	TMEM62	106	Q0P6H9
RHFQGTLELEVGDWK	TMEM62	271	Q0P6H9
KWEEHIAQNSRLELF	CYP4Z2P	166	Q8N1L4
DQDWRQGHQSFLLKT	LINC00158	61	P58513
GIRKQWHEDITQDLR	EP300	566	Q09472
EAWHFARIVELNILG	BDKRB1	196	P46663
IISGHNDQKIRFWDS	ATG16L2	476	Q8NAA4
LDIFLKQQQHWGRTD	CATSPERD	456	Q86XM0
KDVEANFIVWEIHGR	CATSPERE	776	Q5SY80
GFTELHTLWQNEERA	CHD5	1711	Q8TDI0
QHFLEEKQASLWVQG	CDC14A	321	Q9UNH5
VTRFHINWEDNTEKL	ASF1A	146	Q9Y294
QKEEFRHVIAWQQGE	ETV3	46	P41162
HDGNIFIWDLDRGTK	BRWD3	486	Q6RI45
RQWKGHDLNEDGLVS	CALU	111	O43852
INLNVRDHIKDEWEG	AQR	541	O60306
VWNHRVLKDEFLGQV	CAPN5	581	O15484
VGSALLDTANKRHWE	CELSR2	2111	Q9HCU4
LVGLEIWNSQDRFHV	ADAM8	246	P78325
DRDEHWVKDLGSLNG	CEP170B	51	Q9Y4F5
QIEKTFEVNVLAHFW	HSD17B11	136	Q8NBQ5
EITKTFEVNILGHFW	HSD17B13	136	Q7Z5P4
AQIAGKIFREHLWNS	CASP12	66	Q6UXS9
LNWAFIGVDEAHRLK	CHD1	606	O14646
HDLEGNAVKRDSGIW	ERMP1	696	Q7Z2K6
VNRFWKEIHVGDFVR	ATP10A	156	O60312
EQKGLWHHFTDVERQ	ALPK1	1071	Q96QP1
SFENISKWLRNIDEH	RAB10	96	P61026
NELHKFLIWDTAGQE	RAB22A	51	Q9UL26
FKVHLQLWDTAGQER	RAB27B	66	O00194
AHRLQKVTDQYGDIW	PDZRN4	686	Q6ZMN7
REVQLGVADKVSWHS	RBMX2	16	Q9Y388
ADHRVQLDLGLWDKF	RARG	216	P13631
NELHKFLIWDTAGQE	RAB31	51	Q13636
QLSRLQKGHATDEWF	RASA1	676	P20936
HWIEDVRKYAGSNIV	RAB43	111	Q86YS6
FDNIKNWIRNIEEHA	RAB8B	96	Q92930
WELGDDKFIQRGFHV	GSG1L2	76	A8MUP6
SDVVLLNHWKVRNFE	IMMP2L	56	Q96T52
FGWNKVAHIVELDAQ	LARGE2	636	Q8N3Y3
IENLEDLKGHSVREW	MCM2	171	P49736
AFVGELAHFNIWDRK	NPTX1	371	Q15818
HSKLVEDVTNFQGRW	ARHGEF28	211	Q8N1W1
DVTKENRQGWTVLHE	ANKRD13A	66	Q8IZ07
AERAQDIGIWFHILA	ANO7	756	Q6IWH7
KFQIATWGSLIVHEA	MSMO1	46	Q15800
SDGKHDFRVWNAQLI	NOS2	251	P35228
GVLWDVRSAQAIHKF	DCAF1	1241	Q9Y4B6
WHASKVLRIENIGES	IL18R1	276	Q13478
EKWEAFGLRLNHAQQ	MDN1	791	Q9NU22
REGQREWVIQKIHES	IL17RD	401	Q8NFM7
DRWGHQVKLDDLFVT	LSM10	61	Q969L4
NWKEHIDNFLEQLRA	MIS18BP1	466	Q6P0N0
ILFSNHGEIKWIDFV	SSB	251	P05455
GLEHDLDDVNARWKT	DST	5361	Q03001
QGEEIHNEVEFEWLR	FTO	366	Q9C0B1
ELKQFDENTNWLHRV	KIF18A	501	Q8NI77
RWQKLEGNDFHENLV	KY	56	Q8NBH2
LQNGSRHFEDWIDLE	PRKCE	106	Q02156
AKTWVRNSEFLVHEN	ALOXE3	391	Q9BYJ1
VLNHLAEKWFPGQRE	LONRF1	196	Q17RB8
WDEAVFREKILHIQT	DDX58	771	O95786
IHGDKSQQERDWVLN	DDX5	371	P17844
LWNVVSHLVKEFNVG	DDX60L	396	Q5H9U9
QGAVHFNLLDVAKDW	GDF3	176	Q9NR23
GEAVEQRKNHWATEL	C9orf131	671	Q5VYM1
EHIRKQNWFEAFEIL	CPVL	276	Q9H3G5
LIHQKAERVETFLGW	PLSCR3	86	Q9NRY6
VTWRGKHELQVLAVD	FAT2	211	Q9NYQ8
RNFVWVTIHVEDGNL	FAT2	1536	Q9NYQ8
KVWLVHRDGFSLASQ	MYO18A	351	Q92614
VNKWGLHVFRIAELS	PDE4D	401	Q08499
DEGWHILQNKSDDFL	ENPP5	321	Q9UJA9
EWIKALQETIDAFHQ	FGD4	511	Q96M96
FFGTEDHAWIKVEQL	GLYR1	46	Q49A26
DVAEALLHVRNGAWF	INTS2	196	Q9H0H0
QEFIVRGWLHKEVKN	MYO10	1391	Q9HD67
VNGTLYEKHVDEWNI	KDM4A	136	O75164
WAKTSEEFVHINRLA	LRBA	2396	P50851
WLQEKDDFSLGNVHL	LIPG	151	Q9Y5X9
LEILSGDHEQRYWQK	LARP7	521	Q4G0J3
SAWFHDVTVENKLIR	GABRD	131	O14764
WKQQLTEDGDSFLHL	NFKBIA	66	P25963
AHLIQRWFEHVQETK	POLE	341	Q07864
VVNKQLVRHLSGWEA	POLE	1446	Q07864
VHEVEQGIDAKWSLA	EDC3	446	Q96F86
SWLDVRHIEKYVDQG	IRAK3	51	Q9Y616
HVAVQWLEAAAKERG	KBTBD7	241	Q8WVZ9
EAAQFAREHLWGFIK	PPM1D	111	O15297
WRNVLGEQLFEDKSH	PRDM12	41	Q9H4Q4
IAHVTLDKDRQAWNG	FOXRED2	146	Q8IWF2
DQGKARLLTHWEQLD	ORMDL1	76	Q9P0S3
DRKNKGHQAAEIEWL	ERMN	146	Q8TAM6
DKQIQEWETRIFTHS	ODAD1	81	Q96M63
LQEIGDKNDHWFDID	DZIP3	206	Q86Y13
IQWNRKGVDIEISHR	HMCN1	4381	Q96RW7
TDGKHDFRVWNSQLI	NOS1	471	P29475
QWTGRHDAFEILVEL	THAP12	426	O43422
HALGLTERQVKIWFQ	HOXB8	181	P17481
FQHWELIQEDILDTG	NTS	116	P30990
LQVFWEEHKASLGRE	CBY2	196	Q8NA61
KDVQWEFVHGLLENA	DYNC2H1	3911	Q8NCM8
DHSRTEVWKFGNVVI	EFCAB5	1441	A4FU69
IRWKNEVRIHSGSFQ	APOB	3631	P04114
RWKRHGNTELTGQEE	FAM126A	326	Q9BYI3
WDLDIQTNAVIKHRG	PCIF1	176	Q9H4Z3
HWQSKDVILLGDFNA	DNASE1L1	171	P49184
HLTIIQNFDRGKCWE	DOCK4	1256	Q8N1I0
ERGHVEDLYSELNKW	CYP24A1	196	Q07973
IQGILFKVTIHEDSW	C16orf96	836	A6NNT2
FDNLEKHTQWGIDIL	FNBP1	11	Q96RU3
SHEQWLFKRLQEEEA	FILIP1L	696	Q4L180
VLARHGSKIWVNEET	DPP9	496	Q86TI2
NQFLLDSLKHREWGV	FUT11	361	Q495W5
HIGWVREFLNDENKG	FMNL3	121	Q8IVF7
HDGKAVQAQVTWLRL	CCDC40	766	Q4G0X9
TWKRHAEELNGEINK	CCDC73	346	Q6ZRK6
QVFEITENSAKLHWE	COL6A3	2996	P12111
DEGWHQIRLLVTEQD	COL21A1	346	Q96P44
ALWSHLIQFQDREEK	DENND5B	801	Q6ZUT9
GKAFIWSSVLIEHQR	GLI4	301	P10075
RHFWIESNQKREELG	CYP4V2	486	Q6ZWL3
NDILGQHSRKRWENF	CSNK2A2	271	P19784
VQHQEWDGKESTITR	FABP5P3	61	A8MUU1
TNHIGWVREFLNEEN	FMNL2	116	Q96PY5
DWIAALKTVQNREHF	DGKD	136	Q16760
WAEEQRHLETGGQKI	GBF1	1516	Q92538
TQFKWIHIEGRNASE	KHK	131	P50053
QLLEVFWGQDHKVDF	KHNYN	641	O15037
FWGQDHKVDFILQRE	KHNYN	646	O15037
QFQKVLSLCGHEDWI	ELP2	196	Q6IA86
VIRFQKNHGTVWSEI	CYP20A1	191	Q6UW02
ALEAREHGDVLQWAF	B3GNT6	176	Q6ZMB0
HLFLAREGWTVQDVA	PNMA1	106	Q8ND90
TDDFKQGQRHTLLVW	SLC15A1	451	P46059
EVGSRWNVKRHQDIT	PPRC1	1316	Q5VV67
LFRANISLDGWEENH	IFNE	91	Q86WN2
DARGIWHNNEKSFLI	CKMT1A	246	P12532
GLLSASHEQKDAWVR	PHKA2	31	P46019
EFERITQNLDVHFWK	LIPE	526	Q05469
VEQQEHWFEKALRDK	OTUD5	196	Q96G74
KERVLYAWDNGHQLT	OLFML2A	631	Q68BL7
QGFLTEEKVVWESLH	MINDY2	466	Q8NBR6
IENAQHLKLVVFSWE	SYDE2	736	Q5VT97
FNITKTIRQDEWHAL	TMEM178B	151	H3BS89
NEWHAGEIIKLIADY	TIGD6	156	Q17RP2
RKGHFSENETRWIIQ	STK33	206	Q9BYT3
RKGELHFENAVWNSI	STK33	336	Q9BYT3
LIKEAGNEFVQHNTW	PLCD4	531	Q9BRC7
VLDLRKNSHQDFWTV	PRAME	121	P78395
FVIHDIETLWQAEKG	PPARD	211	Q03181
TWDDTKRLIHENQGQ	SYNE1	2066	Q8NF91
ELGSFEDQHRKLNLW	SYNE1	2516	Q8NF91
EHNQFSLGIKELQDW	SYNE1	3281	Q8NF91
VLNVEWLEEFHQSRG	SLC16A14	56	Q7RTX9
HQFRWSEIQKGVREV	CMAS	176	Q8NFW8
EARESGLHQIEVWLQ	PLEKHG4	456	Q58EX7
AVDDRGLYKQDQHWL	SEC11B	106	P0C7V7
SWLVEKNLGELVHRF	SAMD3	11	Q8N6K7
WTIIAGDHDRNLKES	OVCH1	626	Q7RTY7
HTFRVIWTAGDVQKE	RABGGTA	316	Q92696
VEKWGINQLFRNEKH	PKDREJ	866	Q9NTG1
NTEERLWVHGLSKEQ	SEMG1	161	P04279
VGRDWLFHQIEENLR	TANC1	386	Q9C0D5
LLHERGNIEKTFWDL	TANK	131	Q92844
NDIGFWKSEIIHELD	TEKT3	151	Q9BXF9
SEFLAQEKRGEHLSW	SV2A	281	Q7L0J3
KDAWAVRHFIEQGIN	GOT2	256	P00505
NGKWEFLQDGEKIHR	ADPRH	21	P54922
DVIRHVVKNGLLWDE	CMAHP	416	Q9Y471
LQVWIEEQHTGRVEK	CHST9	31	Q7L1S5
KWEEHIAQNSRLELF	CYP4Z1	166	Q86W10
VKFAIDSDQLHQLWE	INPP5J	616	Q15735
WKVSDGIYQHVDVRE	SUPT6H	1371	Q7KZ85
SELLEVNKQWDQHFR	TNIP1	311	Q15025
EHIQWIFQKSLERAS	UBA3	276	Q8TBC4
KDGIFHNSIWLERAA	TNFAIP6	21	P98066
KDVVVGFTQEEWHRL	ZNF793	11	Q6ZN11
WEIVHSFTDEQKRLF	UBE3A	791	Q05086
GILFKQEQAHDDAIW	WDR61	6	Q9GZS3
IKLTQVEHRAGFEWN	SERPINF1	351	P36955
GEAEAWVREQQHLLA	SPTBN2	651	O15020
EQRQCTGVWNHKDEL	RMND5B	306	Q96G75
AWRSFEKQIEEEILH	SMC1B	346	Q8NDV3
WDLALREHAAVNQKG	TUBE1	21	Q9UJT0
VDLQGAELWKRFHEI	TBX18	141	O95935
REQIKISLWNDHFVE	TBC1D8	471	O95759
IGSFIWEQDQHFLIE	TERB2	101	Q8NHR7
ILLIGHRQAFAWVDE	PITPNC1	211	Q9UKF7
KDWFGALHEDANRVI	SPOCK1	211	Q08629
KETWLQREKHAEFQG	ZDBF2	976	Q9HCK1
FGLQILEHVVKFRWN	XPO5	66	Q9HAV4
RSWSVDLGLQENHKV	SLFN12	426	Q8IYM2
QISRDHGWIKLDNNF	VPS13C	3146	Q709C8
RLWKADVHGTVQATF	TECPR2	241	O15040
QWIDHFIEELRTNDK	USP9Y	551	O00507
EQELLSHSWGRETKN	PRAG1	646	Q86YV5
LDGVEQRNLPWKFEH	PSME4	1151	Q14997
RVFSWLQQEGHLSEE	GART	711	P22102
RDIQQHKEEAWVIGS	GART	751	P22102
SKAGQEHLLRFWNEL	UAP1	11	Q16222
HDDVVLEFQWRKQKE	WDR59	281	Q6PJI9
VEEDYLWRIKQLGSH	ZMYM2	1196	Q9UBW7
HSIYIWDVKDINRVG	WDR62	381	O43379
LGDILDWQDIVSFVH	TMEM245	596	Q9H330
WAKHFGQTEIVDLLE	YTHDC2	546	Q9H6S0
LDGVLEVRNEHFWTL	SLC30A6	276	Q6NXT4
EAFHQLTQGRIWKDE	TTC29	206	Q8NA56
EAVKNIIREHFIFWQ	UBXN7	191	O94888
GQKLVEWHQLDVSSF	UBXN7	236	O94888
LEELGIHFDHIWQKT	YIPF7	116	Q8N8F6
GNWIRLYLEEKHSEV	PIGG	386	Q5H8A4
DFQDVGWFLHKLSQQ	TLR5	821	O60602
LVQHQRVHSEEKGWE	ZNF275	116	Q9NSD4
SLFQDLQVEALHKGW	UBR4	486	Q5T4S7
GHRDATEISVLNFWK	ARHGAP21	1806	Q5T5U3
DKHLALQFIDWVLRG	SLC14A2	111	Q15849
EGDSWEQLRLQHLKE	THSD8	36	A0A1W2PP97
HFSQEEWGILNDVQR	ZNF17	16	P17021
EQLWRIFAGVHDEKA	TLE6	161	Q9H808
VVFERSAKQALEWIH	TRIO	1141	O75962
SFILEEWGHLDQSQK	ZKSCAN5	226	Q9Y2L8
GKHEFVNDVASLWEL	TYK2	156	P29597
GLHDSQRLQWEVSFE	VWA5B1	816	Q5TIE3
LKDLQWEHEVLEQRF	GAS8	321	O95995
WEENRVKHQVEYLGL	MYO1F	596	O00160
RKLHVGDFVWVAQET	MUS81	301	Q96NY9
KLEQEEYRTEGISWH	MYO9A	571	B2RTY4
EDLKVNWSHNGSAIR	MYOM1	1486	P52179
IFDKGRVRFWLQAEH	MYOM2	1026	P54296